BMS/Sanofi-Aventis To Study Plavix Efficacy Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
Genetics and concomitant PPI use are possible reasons for the anti-platelet drug’s reduced effectiveness in some patients, according to an FDA “Early Communication.”